GlassScriptPhysician profile
Vinod Kumar Raxwal
NPI 1659386449
$2,731.69
in general payments reported to CMS, 2019-2025
13 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,869 · 2020: $52.97 · 2021: $172 · 2023: $127 · 2024: $256 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,848.04 | 2019 | |
| Edwards Lifesciences Corporation | $182.56 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $167.10 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $131.18 | 2025 | Indigo System |
| Medtronic, INC. | $121.42 | 2021-2024 | Heli-Fx Endoanchor System |
| Abiomed | $95.78 | 2025 | |
| Irhythm Technologies, INC. | $40.25 | 2024 | Zio Monitor, Zio Xt Patch |
| Terumo Medical Corporation | $40.10 | 2020 | |
| Inari Medical, INC. | $31.20 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $22.29 | 2023 | |
| Medtronic Vascular, INC. | $20.56 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.34 | 2024 | Lifevest |
| Cardiovascular Systems INC. | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Raxwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.